Market Cap 37.70B
Revenue (ttm) 363.71M
Net Income (ttm) -913.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -251.24%
Debt to Equity Ratio 0.57
Volume 747,200
Avg Vol 3,100,734
Day's Range N/A - N/A
Shares Out 213.27M
Stochastic %K 37%
Beta 1.01
Analysts Strong Sell
Price Target $212.61

Company Profile

Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is in phase 3 clinical trial for the treatment of mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It also devlops brensocatib, an oral reversible inhibitor of...

Industry: Biotechnology
Sector: Healthcare
Phone: 908 977 9900
Address:
700 US Highway 202/206, Bridgewater, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 1:45 PM
Actionable Trade Alert for $INSM: Market Context: $INSM is currently trading at $177.42, showing a bearish sentiment with an RSI of 30.6, indicating oversold conditions. The stock is below both the 30-day MA of 196.06 and the 50-day MA of 187.69, reinforcing a bearish trend. However, the price is near the 60D low of 143.18, suggesting potential for a reversal. Directional Bias: Given the RSI and proximity to the 60D low, there is a potential for a bullish bounce. The ATR of 9.08 indicates volatility, allowing for significant price movements. Trade Plan: - Suggested Entry: $178.00 - Stop Loss: $170.00 (4.5% risk) - Take Profit Targets: - TP1: $190.00 (6.5% gain) - TP2: $205.00 (15% gain) - TP3: $208.00 (17.3% gain) This plan allows for a strategic entry with a favorable risk-reward ratio. Monitor closely for price action near targets. https://privateprofiteers.com
0 · Reply
pianoman439
pianoman439 Dec. 24 at 9:25 PM
$INSM Merry Christmas fellow Insmed shareholders, may the hope, joy, love, and peace of the Season be with you and your families. Christ is born!
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 24 at 8:19 PM
Enter: $INSM Calls Strike Price: $175 Expiry Date: JAN 16 2026 Buy in Price: $11.90 - $11.90 Sell Price: $25.94 Profit : +118% (Turn every $1 into $2.18) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
ZacksResearch
ZacksResearch Dec. 24 at 6:09 PM
Biotech momentum is BACK — and these names are already up big 👀🚀 $MLYS, $LYEL, $NKTR and $INSM are all up more than 50% in 2025, powered by clinical wins, FDA approvals, and M&A deals that are reviving confidence across the drug and biotech space heading into 2026. See why these high-flyers may still have room to grow 👉 https://www.zacks.com/stock/news/2808693/4-drug-biotech-stocks-rising-more-than-50-in-2025-with-room-to-grow?cid=sm-stocktwits-2-2808693-teaser-26257&ADID=SYND_STOCKTWITS_TWEET_2_2808693_TEASER_26257
0 · Reply
GolfProLife
GolfProLife Dec. 24 at 3:45 PM
$INSM IV still very high from prior to data drop even in the $200 Strike on the April chain looking to get out in front of TPIP data. Thinking the money train on the options side is over boys! That was fun and some ride! Would need a 30 to 40 percent move for those options to print hard, reward risk isn’t there anymore. Especially if market pulls back. Equities side different story.
1 · Reply
OptionRunners
OptionRunners Dec. 23 at 5:40 PM
$INSM seller of the January 16th 2026 $175 puts (ITM) 2,000 times for $9.00
0 · Reply
justiceforb_85
justiceforb_85 Dec. 23 at 5:26 AM
$INSM setback with brensocatib in sinusitis but still with a MOAT in non-CF bronchiectasis. Will be adding.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 23 at 2:31 AM
Enter: $INSM Calls Strike Price: $175 Expiry Date: JAN 16 2026 Buy in Price: $9.90 - $10.30 Sell Price: $21.78 Profit : +120% (Turn every $1 into $2.20) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
TrendZoom_1695
TrendZoom_1695 Dec. 22 at 3:49 PM
$INSM biotech momentum name, if it holds the base and breaks the range high on volume expand, trend confirmation sets up
0 · Reply
pianoman439
pianoman439 Dec. 22 at 11:16 AM
$INSM should be dramatic demand this morning. NASDAQ 100 inclusion day.
1 · Reply
Latest News on INSM
Why Is Insmed Stock Falling Thursday?

Dec 18, 2025, 12:30 PM EST - 7 days ago

Why Is Insmed Stock Falling Thursday?


Insmed Stock Plummets 19%. This Is What Sparked the Selloff.

Dec 18, 2025, 7:12 AM EST - 7 days ago

Insmed Stock Plummets 19%. This Is What Sparked the Selloff.


Insmed Provides Clinical and Business Update

Dec 17, 2025, 4:01 PM EST - 7 days ago

Insmed Provides Clinical and Business Update


Insmed Incorporated (INSM) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 11:16 AM EDT - 2 months ago

Insmed Incorporated (INSM) Q3 2025 Earnings Call Transcript


Insmed To Present at September Investor Conferences

Aug 21, 2025, 7:00 AM EDT - 4 months ago

Insmed To Present at September Investor Conferences


Lung Disease-Focused Insmed 'Must-Own' Name For Investors

Aug 20, 2025, 2:46 PM EDT - 4 months ago

Lung Disease-Focused Insmed 'Must-Own' Name For Investors


Josh Brown's Best Stocks in the Market: Insmed

Aug 19, 2025, 1:04 PM EDT - 4 months ago

Josh Brown's Best Stocks in the Market: Insmed


US FDA approves Insmed's lung disease drug

Aug 12, 2025, 11:42 AM EDT - 4 months ago

US FDA approves Insmed's lung disease drug


Insmed Incorporated (INSM) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 10:20 PM EDT - 4 months ago

Insmed Incorporated (INSM) Q2 2025 Earnings Call Transcript


Is Insmed Stock Overvalued After The 45% Jump?

Jun 16, 2025, 5:05 AM EDT - 6 months ago

Is Insmed Stock Overvalued After The 45% Jump?


Insmed: Company Presses On With Further POC PAH Treatment Data

Jun 10, 2025, 4:30 PM EDT - 7 months ago

Insmed: Company Presses On With Further POC PAH Treatment Data


Insmed's blood pressure drug meets main goal in mid-stage trial

Jun 10, 2025, 7:25 AM EDT - 7 months ago

Insmed's blood pressure drug meets main goal in mid-stage trial


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 1:45 PM
Actionable Trade Alert for $INSM: Market Context: $INSM is currently trading at $177.42, showing a bearish sentiment with an RSI of 30.6, indicating oversold conditions. The stock is below both the 30-day MA of 196.06 and the 50-day MA of 187.69, reinforcing a bearish trend. However, the price is near the 60D low of 143.18, suggesting potential for a reversal. Directional Bias: Given the RSI and proximity to the 60D low, there is a potential for a bullish bounce. The ATR of 9.08 indicates volatility, allowing for significant price movements. Trade Plan: - Suggested Entry: $178.00 - Stop Loss: $170.00 (4.5% risk) - Take Profit Targets: - TP1: $190.00 (6.5% gain) - TP2: $205.00 (15% gain) - TP3: $208.00 (17.3% gain) This plan allows for a strategic entry with a favorable risk-reward ratio. Monitor closely for price action near targets. https://privateprofiteers.com
0 · Reply
pianoman439
pianoman439 Dec. 24 at 9:25 PM
$INSM Merry Christmas fellow Insmed shareholders, may the hope, joy, love, and peace of the Season be with you and your families. Christ is born!
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 24 at 8:19 PM
Enter: $INSM Calls Strike Price: $175 Expiry Date: JAN 16 2026 Buy in Price: $11.90 - $11.90 Sell Price: $25.94 Profit : +118% (Turn every $1 into $2.18) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
ZacksResearch
ZacksResearch Dec. 24 at 6:09 PM
Biotech momentum is BACK — and these names are already up big 👀🚀 $MLYS, $LYEL, $NKTR and $INSM are all up more than 50% in 2025, powered by clinical wins, FDA approvals, and M&A deals that are reviving confidence across the drug and biotech space heading into 2026. See why these high-flyers may still have room to grow 👉 https://www.zacks.com/stock/news/2808693/4-drug-biotech-stocks-rising-more-than-50-in-2025-with-room-to-grow?cid=sm-stocktwits-2-2808693-teaser-26257&ADID=SYND_STOCKTWITS_TWEET_2_2808693_TEASER_26257
0 · Reply
GolfProLife
GolfProLife Dec. 24 at 3:45 PM
$INSM IV still very high from prior to data drop even in the $200 Strike on the April chain looking to get out in front of TPIP data. Thinking the money train on the options side is over boys! That was fun and some ride! Would need a 30 to 40 percent move for those options to print hard, reward risk isn’t there anymore. Especially if market pulls back. Equities side different story.
1 · Reply
OptionRunners
OptionRunners Dec. 23 at 5:40 PM
$INSM seller of the January 16th 2026 $175 puts (ITM) 2,000 times for $9.00
0 · Reply
justiceforb_85
justiceforb_85 Dec. 23 at 5:26 AM
$INSM setback with brensocatib in sinusitis but still with a MOAT in non-CF bronchiectasis. Will be adding.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 23 at 2:31 AM
Enter: $INSM Calls Strike Price: $175 Expiry Date: JAN 16 2026 Buy in Price: $9.90 - $10.30 Sell Price: $21.78 Profit : +120% (Turn every $1 into $2.20) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
TrendZoom_1695
TrendZoom_1695 Dec. 22 at 3:49 PM
$INSM biotech momentum name, if it holds the base and breaks the range high on volume expand, trend confirmation sets up
0 · Reply
pianoman439
pianoman439 Dec. 22 at 11:16 AM
$INSM should be dramatic demand this morning. NASDAQ 100 inclusion day.
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 21 at 1:30 AM
Enter: $INSM Calls Strike Price: $180 Expiry Date: JAN 16 2026 Buy in Price: $9.10 - $9.40 Sell Price: $12.92 Profit : +42% (Turn every $1 into $1.42) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
pianoman439
pianoman439 Dec. 20 at 4:29 PM
$INSM truist upgrades Insmed to strong buy. Interesting!
0 · Reply
1iquid
1iquid Dec. 20 at 1:27 PM
OptionWizards Tip (education only): Before trading options on AIG, INSM, or CCI, review the contract's historical average volume to assess execution qualit… $AIG $INSM $CCI Not financial advice.
0 · Reply
MoonDrinker0
MoonDrinker0 Dec. 20 at 3:28 AM
$INSM 200$
0 · Reply
leon_dedrick
leon_dedrick Dec. 19 at 9:20 PM
$INSM I got some stupid puts here for Feb 70 dollar puts Enough time to see if sales are as successful for that 5 billion TAM 28.1 million is the number to beat in a convincing manner that justifies nearly a 40 billion marketcap
0 · Reply
Grouphome
Grouphome Dec. 19 at 5:18 PM
2 · Reply
GolfProLife
GolfProLife Dec. 19 at 4:35 PM
$INSM solid bounce off the lows yesterday. Next big catalyst is TPIP, the 04/17/26 $200 chain has the most Open Interest. Not a massive bet yet, but that’s where money is holding.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 3:39 PM
Actionable Trade Alert for $INSM: Market Context: $INSM is currently trading at $166.55, significantly below its 60-day high of $212.75 and near its 60-day low of $134.01. The RSI at 20.84 indicates that the stock is in oversold territory, suggesting potential for a rebound. Directional Bias: Given the low RSI and the proximity to the 60-day low, there is a bullish bias in the short term. However, the stock remains below both the 30-day MA of 197.93 and the 50-day MA of 186.64, indicating a bearish trend in the longer term. Trade Plan: - Suggested Entry: $167.00 - Stop Loss: $160.00 (4.0% risk) - Take Profit Targets: 1. $180.00 (7.6% gain) 2. $195.00 (16.5% gain) 3. $195.00 (17.1% gain) With a potential ROI of over 17% on the third target, this trade presents a favorable risk-reward scenario. Monitor closely for market conditions that may affect price movement. https://privateprofiteers.com
0 · Reply
pianoman439
pianoman439 Dec. 19 at 2:46 PM
$INSM always good not to trade on emotion!
2 · Reply
StockAnalyst_SA
StockAnalyst_SA Dec. 19 at 2:15 PM
Good Morning! Futures Flat $ORCL Deal in place for TikTok acquisition $NKE pt cut $75 from $84 @ Piper $RKT int Buy @ Jefferies pt $25 $INSM int Buy @ Truist pt $205 $LYB d/g Equal weight @ WFC pt $45
0 · Reply
RunnerSignals
RunnerSignals Dec. 19 at 5:49 AM
Very late-night movers 🌙 $NKE $FCEL $INSM $CORZ $FDX kept traders busy after the bell. earnings pops. biotech shock. analyst love. curious who really won the night? Read on https://stocksrunner.com/news/2025-12-18-late-night-market-recap
0 · Reply
TickerSpark_Stocks
TickerSpark_Stocks Dec. 18 at 11:43 PM
Hard data: Insmed reported a clinical setback that missed a key endpoint and saw ~5x normal volume. That turns the story from growth to survival. Key questions: which data failed, regulatory fallback, cash runway and potential deal interest. Do the homework. $INSM INSM deep dive here: https://tickerspark.ai/?ticker=INSM
1 · Reply